158 related articles for article (PubMed ID: 2676224)
1. Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cooperative Osteosarcoma Study Group COSS.
Bielack SS; Erttmann R; Looft G; Purfürst C; Delling G; Winkler K; Landbeck G
Cancer Chemother Pharmacol; 1989; 24(6):376-80. PubMed ID: 2676224
[TBL] [Abstract][Full Text] [Related]
2. Intraarterial chemotherapy for osteosarcoma: does the result really justify the effort?
Bielack SS; Bieling P; Erttmann R; Winkler K
Cancer Treat Res; 1993; 62():85-92. PubMed ID: 8096763
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model.
Robl B; Botter SM; Pellegrini G; Neklyudova O; Fuchs B
J Exp Clin Cancer Res; 2016 Jul; 35(1):113. PubMed ID: 27421768
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
Fuchs N; Bielack SS; Epler D; Bieling P; Delling G; Körholz D; Graf N; Heise U; Jürgens H; Kotz R; Salzer-Kuntschik M; Weinel P; Werner M; Winkler K
Ann Oncol; 1998 Aug; 9(8):893-9. PubMed ID: 9789613
[TBL] [Abstract][Full Text] [Related]
6. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Kotz R; Greenshaw C; Jürgens H; Ritter J; Kusnierz-Glaz C; Erttmann R
Cancer; 1990 Oct; 66(8):1703-10. PubMed ID: 2208024
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
8. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
9. Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary results.
Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Purfürst C; Heise U; Jürgens H; Kotz R; Gadner H; Ritter J
Chir Organi Mov; 1990; 75(1 Suppl):54-6. PubMed ID: 2249558
[No Abstract] [Full Text] [Related]
10. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
11. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
12. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
13. Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues.
Jaffe N
Cancer Treat Res; 1993; 62():75-84. PubMed ID: 8096762
[TBL] [Abstract][Full Text] [Related]
14. [Intra-arterial infusion of cisplatinum in bone and soft tissue tumors].
Matsumoto S; Kawaguchi N; Amino K; Manabe J; Furuya K; Isobe Y
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1018-24. PubMed ID: 3471184
[TBL] [Abstract][Full Text] [Related]
15. Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities.
Bacci G; Picci P; Avella M; Ferrari S; Casadei R; Ruggieri P; Brach del Prevert A; Tienghi A; Battistini A; Mancini A
J Chemother; 1992 Jun; 4(3):189-95. PubMed ID: 1517815
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum.
Benjamin RS; Chawla SP; Carrasco CH; Raymond AK; Murray JA; Armen T; Patel S; Wallace S; Ayala A; Papadopoulos NE
Ann Oncol; 1992 Apr; 3 Suppl 2():S3-6. PubMed ID: 1622860
[TBL] [Abstract][Full Text] [Related]
17. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
18. Isolated lower extremity chemotherapeutic infusion for treatment of osteosarcoma: experimental study and preliminary clinical report.
Wang MQ; Dake MD; Wang ZP; Cui ZP; Gao YA
J Vasc Interv Radiol; 2001 Jun; 12(6):731-7. PubMed ID: 11389225
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial cis-platinum for patients with inoperable skeletal tumors.
Mavligit GM; Benjamin R; Patt YZ; Jaffe N; Chuang V; Wallace S; Murray J; Ayala A; Johnston S; Hersh EM; Calvo DB
Cancer; 1981 Jul; 48(1):1-4. PubMed ID: 6263447
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults.
Hugate RR; Wilkins RM; Kelly CM; Madsen W; Hinshaw I; Camozzi AB
Clin Orthop Relat Res; 2008 Jun; 466(6):1292-301. PubMed ID: 18437502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]